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Purpose: To assess sexual function in the first postoperative year after elective endovas-
cular aneurysm repair (EVAR) and open repair (OR) of abdominal aortic aneurysm (AAA).
Methods: In the Dutch Randomized Endovascular Aneurysm Management (DREAM) trial,
153 patients (141 men; mean age 71 years, range 53–85) were randomly allocated to EVAR
(n577) or OR (n576). Sexual functioning was evaluated preoperatively and at 5 times in
the first postoperative year (3, 6, 13, 26, and 52 weeks) using a questionnaire derived from
the Medical Outcomes Study. The proportions of patients reporting sexual dysfunction for
any of 5 aspects (interest, pleasure, engagement, orgasm, and erection) and any increase
in the magnitude of dysfunction were compared between EVAR and OR.
Results: Preoperatively, the proportion of patients reporting sexual dysfunction in at least
1 aspect was 66% for the OR group and 74% in the EVAR group (p5NS). Surgery had a
clear impact on sexual dysfunction. The proportion of patients reporting sexual dysfunc-
tion on at least 1 aspect increased to 79% in the OR group and 82% in the EVAR group.
The magnitude of sexual dysfunction increased in both groups on all 5 aspects at 3 weeks
postoperatively, but this was more pronounced in the OR group (interest: OR p50.038 vs.
EVAR p50.071; pleasure: OR p50.009 vs. EVAR p50.065; engagement: OR p50.006 vs.
EVAR p50.054; orgasm OR p50.023 vs. EVAR p50.112, and erection: OR p50.046 vs. EVAR
p50.030). At 6 weeks, the OR group still reported a significant increase in 3 aspects (plea-
sure p50.031, engagement p50.010, and orgasm p50.003), whereas the EVAR group no
longer showed a significant difference. From 3 months on, both groups had returned to
baseline.
Conclusions: EVAR and open elective AAA repair both have an impact on sexual function
in the early postoperative period. After EVAR, recovery to preoperative levels is faster than
after open repair, but at 3 months, sexual dysfunction levels are similar in both groups.
J Endovasc Ther 2004;11:613–620
Key words: abdominal aortic aneurysm, endovascular repair, surgical repair, comparative
study, sexual dysfunction, questionnaire, outcome analysis, randomized trial
l l
614 SEXUAL DYSFUNCTION AFTER AAA REPAIR
Prinssen et al.
J ENDOVASC THER
2004;11:613–620
This study was funded by the Dutch Health Insurance Council (OG68).
Presented at the International Congress XVII on Endovascular Interventions, Scottsdale, Arizona, USA,
February 8–12, 2004.
Address for correspondence and reprints: Jan D. Blankensteijn, MD, Chief Department of Vascular
Surgery, Surgery 410, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen,
The Netherlands. Fax: 31-24-3540501; E-mail: j.blankensteijn@chir.umcn.nl
Open abdominal aortic aneurysm (AAA) re-
pair has been associated with impairment of
sexual functioning. Sexual dysfunction after
open repair (OR) of AAA is often attributed to
autonomic nerve injury and changes in pelvic
blood supply. As endovascular aneurysm re-
pair (EVAR) does not require dissection in the
area of the iliac bifurcation, it is expected not
to affect sexual functioning. However, little is
known about this subject. There is clinical ev-
idence that sexual problems have a mixed eti-
ology, with physical, medical, social, and psy-
chological components. So, it is not unlikely
that other factors may be responsible for the
sexual impairment after OR also.1,2 Only a few
studies have focused on sexual dysfunction
after AAA repair, most in conjunction with
conventional surgery.3–5 The aim of our study
was to assess sexual functioning in the first
postoperative year after elective EVAR and OR
in a randomized study.
METHODS
Study Design and Patient Samples
In the Dutch Randomized Endovascular An-
eurysm Management (DREAM) trial, 153 pa-
tients (141 men; mean age 71 years, range
53–85) suitable for both treatments were ran-
domly allocated to EVAR (n577) or OR (n576)
between November 1999 and August 2002.
There was 1 crossover from OR to EVAR, but
the analysis was based on intention to treat.
The study design has been described in detail
elsewhere.6 The Institutional Review Boards
of all participating hospitals (Appendix) ap-
proved the study, and informed consent was
obtained from each patient.
Sexual functioning was assessed on a scale
adapted from the Medical Outcomes Study
(MOS),7 which consists of 5 questions con-
cerning sexual functioning (Table 1). The
questionnaire was sent to all patients preop-
eratively and at 5 time points in the first post-
operative year (3, 6, 13, 26, and 52 weeks). If
the questionnaire was not filled out complete-
ly, questions were completed with a tele-
phone call. For analysis purposes, a patient
was considered to report sexual dysfunction
for each of the items if any of the following
answers were given: completely agree, partly
agree, and partly disagree.
Statistical Analysis
Baseline characteristics (age, gender, SVS/
AAVS [Society for Vascular Surgery/American
Association for Vascular Surgery] risk score,8
and medication) of patients in both trial arms
were compared with the Student t and chi-
square tests. The proportion of patients re-
porting sexual dysfunction on at least 1 of the
5 aspects and the proportion for each individ-
ual aspect of sexual functioning were calcu-
lated and compared between the EVAR and
OR groups using the Fisher’s exact test.
Changes in the magnitude of sexual dysfunc-
tion over time versus the preoperative value
were analyzed with the Wilcoxon signed rank
test. Analyses were performed using SPSS
version 11.0 (SPSS Inc., Chicago, IL, USA).
P,0.05 was considered significant.
RESULTS
There were no differences in baseline char-
acteristics between the EVAR and OR groups
(Table 2). Both pre and postoperatively, there
were no significant differences between the
trial arms in the number of patients using any
b-blockers, calcium-channel blockers, digox-
in, or diuretics. Preoperatively, 64% of the pa-
tients in the OR group used one or more of
these medications compared to 51% in the
EVAR group.
In the OR group, 47 patients received an
aorto-aortic tube graft and 30 a bifurcated
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TABLE 1
Medical Outcomes Study Questionnaire on Sexual Functioning
Do you agree or disagree with the following statements?
Completely
agree
Partly
agree
Partly
disagree
Completely
disagree
a. I’m not interested in sex □ □ □ □
b. I have difficulties in relaxing and enjoying sex □ □ □ □
c. I have difficulties in becoming sexually aroused □ □ □ □
d. I have difficulties in having an orgasm □ □ □ □
e. I have difficulties in getting and/or keeping an erection (for men only). □ □ □ □
l l
graft; in the EVAR group, all endografts were
bifurcated except 1 tube graft. Internal iliac ar-
tery patency after surgery was unchanged in
72/77 (94%) patients assigned to the OR group
and 61/76 (80%) patients assigned to the
EVAR group (p50.017). One or bilateral patent
internal iliac arteries were lost in 5 OR and in
14 EVAR patients; in addition, a single internal
iliac artery (with preexistent contralateral oc-
clusion) was sacrificed in 1 EVAR patient.
Postoperatively, impaired sexual functioning
was reported spontaneously at office visits by
2 patients in the OR group and by 1 in the
EVAR patients.
The preoperative questionnaire response
rate was 69% in the OR group and 87% in the
EVAR group (p50.007). The postoperative re-
sponse rates for OR and EVAR were 61% ver-
sus 66% (p50.542) at 3 weeks, 61% versus
66% (p50.542) at 6 weeks, 71% versus 70%
(p50.818) at 13 weeks, 69% versus 68%
(p50.956) at 26 weeks, and 69% versus 67%
(p50.819) at 52 weeks.
The preoperatively reported sexual dys-
function rate (Table 3) was high in both
groups; for the individual items, the propor-
tions varied between 48% and 56% in the OR
group and 53% and 60% in the EVAR group.
Preoperatively, the percentage of patients re-
porting sexual dysfunction on any of the 5 as-
pects was 66% in OR group and 74% in the
EVAR group (p5NS). There was no statisti-
cally significant difference in the proportion of
patients reporting sexual dysfunction be-
tween the 2 groups for any of the 5 aspects
at any time point or for sexual dysfunction in
at least 1 aspect.
Nevertheless, surgery did have an impact
on sexual functioning in both groups (Figure).
Three weeks after surgery, the reported rate
of sexual dysfunction on any of the 5 aspects
increased to 79% in the OR group and 82% in
the EVAR group. Looking at the reported
changes in magnitude of sexual dysfunction
at 3 weeks compared to preoperative values
(Table 4), the OR group reported a significant
increase on all 5 aspects (interest p50.038,
pleasure p50.009, engagement p50.006, or-
gasm p50.023, and erection p50.046). In the
EVAR group, there was an increased magni-
tude of sexual dysfunction on all aspects also,
but only 1 (erection p50.030) reached statis-
tical significance (other aspects not signifi-
cantly increased: interest p50.071, pleasure
p50.065, engagement p50.054, and orgasm
p50.112). Six weeks postoperatively, the OR
group still reported a significant increase in
the magnitude of sexual dysfunction on 3 as-
pects (pleasure p50.031, engagement
p50.010, and orgasm p50.003; other aspects
not significantly increased: interest p50.168
and erection p50.111). The EVAR group
showed no significant difference at 6 weeks
(interest p50.674, pleasure p50.855, engage-
ment p50.773, orgasm p50.768, and erection
p50.519). From 3 months on, both groups
had returned to their preoperative level of
sexual functioning.
DISCUSSION
Few reports addressing the impact of OR and
EVAR on sexual functioning have been pub-
lished. In the available literature, most studies
are retrospective in nature and focus primar-
ily on impotence and erectile dysfunction af-
ter conventional open AAA repair.4,5,9 To our
knowledge, no randomized study has com-
pared sexual function after OR and EVAR until
now.
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TABLE 2
Baseline Characteristics According to the SVS/AAVS Risk Factor
OR (n576) EVAR (n577)
Men 69 (91%) 72 (93%)
Median age, y (range) 70 (53–85) 70 (55–82)
Diabetes
Not available 0 1 (1%)
None (0) 72 (95%) 71 (92%)
Adult onset, diet (1) 3 (4%) 4 (5%)
Adult onset, insulin (2) 1 (1%) 1 (1%)
Tobacco use
Not available 1 (1%) 1 (1%)
None or .10 y ago (0) 39 (51%) 28 (36%)
Not current, ,10 y ago (1) 13 (17%) 17 (22%)
Current, ,1 pack/d (2) 15 (20%) 28 (36%)
Current, .1 pack/d (3) 8 (11%) 3 (4%)
Hyperlipidemia
Not available 7 (9%) 3 (4%)
Normal levels (0) 37 (49%) 44 (57%)
Mild elevation, diet (1) 7 (9%) 8 (10%)
Strict dietary control (2) 1 (1%) 1 (1%)
Diet 1 drug control (3) 24 (32%) 21 (27%)
Hypertension
Not available 0 2 (3%)
None (0) 40 (54%) 35 (45%)
Single-drug therapy (1) 23 (30%) 27 (35%)
2-drug therapy (2) 11 (14%) 11 (14%)
.2 drugs or uncontrolled (3) 2 (3%) 2 (3%)
Carotid disease
Not available 0 1 (1%)
No symptoms (0) 67 (88%) 67 (87%)
Asymptomatic, but disease (1) 4 (53%) 1 (1%)
TIA or temporary stroke (2) 3 (39%) 5 (6%)
Stroke/neurological deficit (3) 2 (3%) 3 (4%)
Cardiac status
Not available 0 1 (1%)
Asymptomatic, normal ECG (0) 39 (51%) 44 (57%)
Asymptomatic, remote or occult Ml (1) 33 (43%) 25 (32%)
Stable AP; drug-compensated CHF (2) 4 (5%) 7 (9%)
Renal status
Not available 1 (1%) 2 (3%)
No renal disease (0) 70 (92%) 69 (90%)
Creatinine ,210 mmol/L (1) 5 (7%) 6 (8%)
Pulmonary status
Not available 0 2 (3%)
Asymptomatic, PFT .80% of predicted (0) 64 (84%) 51 (66%)
Asymptomatic, PFT 65% to 80% of predicted (1) 9 (12%) 21 (27%)
PFT 35% to 65% of predicted (2) 3 (4%) 3 (39%)
Medication affecting sexual function 49 (64%) 39 (51%)
Digoxin 5 (66%) 3 (4%)
Diuretics 12 (16%) 10 (13%)
Calcium-channel blockers 16 (21%) 14 (18%)
Beta-blockers 33 (43%) 26 (34%)
l l
TIA: transient ischemic attack, ECG: electrocardiogram, CHF: congestive heart failure, AP:
angina pectoris, MI: myocardial infarction, PFT: pulmonary function test.
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TABLE 3
Proportion of Patients Reporting Sexual Dysfunction
Sexual
Dysfunction
(aspect)
Pre, %
OR EV
3 Weeks,
%
OR EV
6 Weeks,
%
OR EV
13 Weeks,
%
OR EV
26 Weeks,
%
OR EV
52 Weeks,
%
OR EV
Interest 48 53 67 77* 70 60 51 55 52 58 45 63
Pleasure 56 55 72 84* 74 65 62 59 58 71 51 70
Engagement 55 60 76 77 77* 58 61 53 66 63 53 64
Orgasm 53 57 72 78 77* 55 60 52 65 59 61 54
Erection 54 57 73 74* 72 58 58 56 60 57 60 54
Any aspect 66 74 79 82 77 68 69 70 76 71 66 69
l l
* Significantly different from Pre at p,0.05.
FigurelProportion of sexual dysfunction for 5 aspects over time in the open (A) and the
EVAR (B) groups.
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TABLE 4
Proportion of Patients Reporting an Increase in Sexual Dysfunction
Compared to the Preoperative Situation
Sexual
Dysfunction
(aspect)
3 Weeks,
%
OR EV
6 Weeks,
%
OR EV
13 Weeks,
%
OR EV
26 Weeks,
%
OR EV
52 Weeks,
%
OR EV
Interest 45* 44 35 20 19 26 12 24 17 35
Pleasure 41† 42 33* 29 25 22 18 26 23 24
Engagement 47† 38 40* 17 24 22 24 26 24 38
Orgasm 37* 33 35‡ 16 24 13 21 14 26 27
Erection 31* 53* 22 18 17 19 20 20 22 26
l l
* Significantly different from Pre at p,0.05.
† Significantly different from Pre at p,0.01.
‡ Significantly different from Pre at p,0.005.
Although surgery did not result in a signif-
icant difference in the proportion of patients
reporting sexual dysfunction between the 2
groups, the impact of surgery on sexual func-
tion in the OR group was greater than in the
EVAR group. This effect could be demonstrat-
ed despite a higher number of internal iliac
arteries being lost or sacrificed in the EVAR
group, which underscores the multifactorial
pathogenesis of sexual dysfunction after sur-
gery.
The preoperative rate of sexual dysfunction
on any aspect was ;70% in our study, which
may appear high compared to other re-
ports,3,4 but there are several possible expla-
nations for this difference. First, we had a bet-
ter rate of response to our questionnaire than
some other investigators have reported.3,4,10
The prospective study design and the willing-
ness of participants to enroll in a randomized
trial were factors in favor of compliance. In a
retrospective setting, patients who already
have sexual dysfunction are probably less
likely to respond to a questionnaire assessing
sexual functioning. This bias leads to an un-
derestimation of the percentage of patients
having sexual dysfunction.
Another explanation for the high sexual
dysfunction rate in our study could be that the
questionnaires were sent after randomization.
The knowledge of having a potentially life-
threatening disease and awaiting an opera-
tion may have had an impact on quality of life
and sexual functioning. Furthermore, the in-
cidence of sexual dysfunction increases with
age and the presence of comorbidities.11–13
Vascular disease, smoking, ischemic heart
disease, hypertension, and diabetes are
known to have an impact on sexual func-
tion.10,14,15
Xenos et al.3 and Lee et al.4 both performed
retrospective studies by sending question-
naires to all AAA patients who underwent OR
and asked them to recall their sexual function
preoperatively and 3 months postoperatively.
As shown in other studies and also in ours,
the impact of the operation on the quality of
life has faded 3 months after the procedure.
As such, this seems an acceptable time frame
to assess sexual functioning. Furthermore, it
does not seem likely that sexual function will
change or improve after 3 months, as also
shown in our data, so the reported postop-
erative sexual dysfunction rate at 3 months
appears reliable. However, as Lee et al.4 also
stated, the incidence of preoperative sexual
dysfunction may be clouded by recall bias in
retrospective studies. Many responders prob-
ably remember their sexual function to be
better than it really was prior to the operation.
Accordingly, the true prevalence of sexual
dysfunction likely will be underestimated in
these studies. Mulligan and Katz16 examined
libido and erectile function in elderly men and
found that only 15% had sexual intercourse,
mostly due to erectile failure. Also, other
studies reported sexual dysfunction rates in
the same range as we found in our study.17,18
Xenos et al.3 compared erectile function af-
ter OR and EVAR in a retrospective study de-
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sign. They found significantly decreased sex-
ual functioning after OR and no deterioration
after EVAR. In our study, no differences where
found between OR and EVAR. A likely expla-
nation for this may be that Xenos’ study was
not randomized. Despite the fact that baseline
characteristics did not differ significantly be-
tween their groups, this retrospective study
may have been flawed by bias.
A potential shortcoming of our study is that
we did not record information about the op-
portunities for sexual activity, i.e., of having a
spouse or a partner, which might have had an
effect on the results. Another issue may be
the medication taken by patients with AAA.
Apart from the vascular disorder and other
risk factors, some types of medication are
known to possibly impair sexual function.19
However the relationship to a specific type of
medication can be difficult to determine be-
cause existing comorbidities affect sexual
function also.
Sexual functioning would appear to be an
integral part of quality of life (QoL), which the
DREAM trial also assessed.20 The preopera-
tive QoL scores of the study group were lower
on several domains of the Short Form-36
questionnaire but did not significantly differ
from the scores of the age-matched general
Dutch population. At the 3-week interval, both
trial arms reported a significantly decreased
QoL, but the OR group had significantly lower
scores than the EVAR group. At 6 weeks, both
groups showed a (partial) recovery of the
QoL. Three months after surgery, both trial
arms had regained their preoperative level.
However, as the reported sexual dysfunction
in this study is high, this might indicate that
sexual activity in this population does not
play an important role.
Another limitation in evaluating sexual dys-
function is that there are no validated ques-
tionnaires available on the issue. The Medical
Outcomes Study evaluation we have used
was selected as the most appropriate from
several nonvalidated questionnaires.7 Better
tools need to be developed to study sexual
function after surgery.
Very few patients reported sexual dysfunc-
tion spontaneously at office visits. The high
rate of preoperative sexual dysfunction
makes it impossible for this study to analyze
sexual dysfunction in patients who reported
normal sexual function preoperatively. A
much larger study would be needed to have
enough power to detect differences between
treatment groups. Taking into account that
the preoperative rate of sexual dysfunction is
.65% in the target population and that ran-
domized studies like these are increasingly
hard to conduct, it is unlikely this type of ev-
idence will ever be available. Nevertheless,
reanalysis of the DREAM data will be per-
formed after all the questionnaires are avail-
able up to the 24-month follow-up.
In conclusion, sexual dysfunction rates are
high in this population, even at the outset. En-
dovascular and open elective AAA repair both
have an impact on sexual functioning in the
early postoperative period. After EVAR, recov-
ery to preoperative levels is faster than after
open repair, but at 3 months, sexual dysfunc-
tion levels are similar in both groups.
APPENDIX
Centers participating in the DREAM trial: The
Netherlands: Catharina Hospital, Eindhoven:
J. Buth, A.V. Tielbeek; University Hospital
Groningen: E.L.G. Verhoeven, T. Prins; St. Elis-
abeth Hospital, Tilburg: J.F. Hamming, L.E.H.
Lampmann; University Medical Center Maas-
tricht: G.W.H. Schurink, M. de Haan; Academ-
ic Medical Center Amsterdam: R. Balm, J.A.
Reekers; Maxima Medical Center, Veldhoven:
M.H.M. Bender, H. Pasmans; University Med-
ical Center Leiden: M.J.T. Visser, E. van der
Linden; University Medical Center Utrecht:
J.D. Blankensteijn, W.P.Th.M. Mali; Medical
Center Rijnmond Zuid, Rotterdam: A.A.E.A.
de Smet, D. Vroegindeweij; Rijnstate Hospital,
Arnhem: S.M.M. van Sterkenburg, G.B. ten
Haken; Martini Hospital, Groningen: J.H.B.
Boomsma, H.R. van Dop; Medical Center
Haaglanden, Westeinde, ‘s-Gravenhage:
J.C.A. de Mol van Otterloo, T.P.W. de Rooij;
Erasmus Medical Center, Rotterdam:
M.R.H.M. van Sambeek, P. Pattynama; Ley-
enburg Hospital, ‘s-Gravenhage: C.M.A. Bru-
ijninckx, H. van Overhagen; University Medi-
cal Center St. Radboud, Nijmegen: J.D.
Blankensteijn, L. Schulze Kool; St. Franciscus
Gasthuis, Rotterdam: A.C. van der Ham,
620 SEXUAL DYSFUNCTION AFTER AAA REPAIR
Prinssen et al.
J ENDOVASC THER
2004;11:613–620
J.J.I.M. van der Velden; Academic Medical
Center VU, Amsterdam: W. Wisselink, F.C. van
den Berg; Albert Schweitzer Hospital, Dor-
drecht: R.P. Tutein Nolthenius, T.R. Hendriksz;
OLVG, Amsterdam: A.C. Vahl, C. de Vries; Me-
ander Medical Center, Amersfoort: A.J.C.
Mackaay; Bronovo Hospital, ‘s-Gravenhage:
H.J. Smeets; Vlietland Hospital, Schiedam:
L.M.C. van Dortmont; Deventer Hospital:
B.H.P. Elsman; Hospital Bernhoven, Oss: T.M.
Smits; Jeroen Bosch Hospital, ‘s-Hertogen-
bosch: R.M.M. van Loenhout, M.J. Rutten;
Atrium Medical Center, Heerlen: J.A.W. Tei-
jink, H.F. Odink; Oosterschelde Hospital, Goes:
E.N. Yilmaz; Maxima Medical Center Eindho-
ven: G. den Butter.
Belgium: University Hospital Antwerpen: J.
Poniewierski; University Medical Center Gent:
F.E.G. Vermassen; St. Jozef Hospital, Turn-
hout: P. Stabel; St. Trudo Hospital, St. Truiden:
F. van Elst.
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